Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 14, 2014
Alzheimer's Society's flagship Drug Discovery programme is an exciting new approach to developing treatments for dementia. To explain how our programme works, we've worked with our ambassador Fiona Phillips to make this short Drug Discovery video. Watch it, share it with friends and help us raise awareness of the vital research Alzheimer's Society is funding.
Alzheimer's Society's flagship Drug Discovery programme is accelerating the search for new and better dementia treatments. Launched in 2011, the programme has already brought two promising candidate drugs into clinical trials and there is much more research planned for the coming years.
Our innovative approach means that new, better treatments could be available in half the time of a standard drug, bringing hope to people with dementia and their carers.
It takes about 20 years and millions of pounds to develop a new drug from scratch.
Drug Discovery focuses on 'drug repurposing', which takes drugs that are already being used to treat other conditions and tests their potential as a treatment for dementia.
Alzheimer's Society is leading the fight against dementia. Support our Drug Discovery programme and help us get closer to a cure.
Alzheimer's Society is the leading support and research charity for people with dementia, their families and carers.
What is dementia?
The term 'dementia' is used to describe the symptoms that occur when the brain is affected by specific diseases and conditions. Symptoms of dementia include loss of memory, confusion and problems with speech and understanding.